People infected with HIV must take antiretroviral drugs for life. But engineered antibodies appeared to suppress the virus ...

HIV treatment has significantly evolved over the past 30 years, transforming HIV from a fatal disease to a manageable chronic ...

UCSF researchers have found a treatment for HIV that shows potential as a long-term solution for the chronic disease that, up ...

HIV treatment has delivered life-altering advantages. Antiretroviral therapy has led to a reduced mortality and improved life ...

UCSF researchers have made strides toward an HIV cure, showing experimental immunotherapy can help control the virus without ...

Pill burden decreases and antiretroviral regimens simplify for many of the participants who start lenacapavir.

Merck said on Wednesday its experimental oral HIV medicine was found to be non-inferior to Gilead Sciences' top-selling drug Biktarvy in a late-stage study involving previously untreated adult ...

Here are four things to know. 1. Biktarvy is a once-daily, triple-combination tablet used to treat HIV infections. 2. The drug’s wholesale price will be about $36,000 per year, which falls in line ...

An oral HIV drug helped patients with center-involved diabetic macular edema achieve improvements in visual acuity, according ...

HIV treatment has entered a revolutionary new era, one where a single yearly injection can keep the virus undetectable, and ...

Researchers led by a team from Mass General Brigham and the Ragon Institute have discovered why some people living with HIV ...

Sofosbuvir, a hepatitis C treatment drug, can adversely interact with tenofovir disoproxil, a HIV treatment drug, according to research led by Bingfang Yan, PhD, professor of biomedical and ...